-
Russian & Swedish Scientists Slow Down Mice Aging with Synthetic Antioxidant
A new experiment conducted by a joint team of Russian and Swedish scientists has produced groundbreaking results in slowing down the ageing process of...
2017-04-18 15:17 -
FDA Approves Two Hepatitis C Drugs - Sovaldi and Harvoni - for Pediatric Patient
The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to tre...
2017-04-18 10:14 -
Insys's 'reckless' Subsys marketing led to patient's death, lawsuit alleges
Embroiled in a web of allegations and investigations over Subsys marketing, Insys Therapeutics faces a new lawsuit from parents who said their daughte...
2017-04-01 10:39 -
Is Novartis looking at divesting some of its respiratory drugs? Drugmaker says n
A year ago, Novartis inked a high-profile partnership with tech giant Qualcomm to develop a smart inhaler, in a clear bid to compete with its chief ri...
2017-04-01 10:37 -
Post-disastrous Valeant investment, soul-searching Ackman reflects on lessons le
One-time Valeant enthusiast and hedge fund manager Bill Ackman has already lamented his huge bet on the now-imploded drugmaker as “one very big mista...
2017-04-01 10:34 -
Merck KGaA disses Ocrevus-Rebif price comparison as 'misleading and oversimplifi
Roche surprised industry watchers on Tuesday when it placed a $65,000 list price on multiple sclerosis blockbuster-to-be Ocrevus, sparking comparisons...
2017-04-01 10:31 -
Vertex trumpets data for new CF combo it hopes can outdo sluggish Orkambi
Vertex’s cystic fibrosis combo, Orkambi, hasn’t exactly torn up the market since hitting the scene in 2015. Now, though, the company has a new combo...
2017-04-01 10:27 -
Pharma's most-valuable brands? J&J, Pfizer and Merck. Valeant, not so much
U.S. pharma brands jumped in value almost across the board in Brand Finance's annual look at the nation’s most valuable. The lone exception? Valeant ...
2017-04-01 10:13 -
Warp Drive Bio forms technology alliance with GSK
Warp Drive Bio has partnered with GSK to discover potential therapeutics in oncology and other diseases.
2017-04-01 10:09 -
Oxford BioDynamics participates in rheumatoid arthritis triggers study
Oxford BioDynamics is participating in a collaboration to identify the biological factors that trigger disease relapses, known as flares, in Rheumatoi...
2017-04-01 10:01
Hot News
- Heubach GmbH required to files... Apr 24, 2024
- Huadong Medicine Achieves Stro... Apr 19, 2024
- Pursell biodegradable coating ... Apr 24, 2024
- BMS (Bristol-Myers Squibb) Ann... Apr 28, 2024
- Breaking the Market: The Pheno... Apr 28, 2024
Related Products